May 04, 2018 - Penumbra (PEN) deepens its focus on driving innovation, ramping up production and expanding geographies.
May 04, 2018 - Envision Healthcare's (EVHC) Q1 earnings should see an upside from higher revenues at both its segments.
May 03, 2018 - With no approved product in Celldex Therapeutics' (CLDX) portfolio, investor focus is on its immuno-oncology pipeline.
May 03, 2018 - With no approved product in Geron's (GERN) portfolio, investor focus continues to remain on its sole pipeline candidate, imetelstat, ahead of the first-quarter earnings release.
May 03, 2018 - We will initiate coverage on seven biotechnology stocks.These seven companies are primarily picked for their current valuation, pipeline prospects, financial figures, and likelihood of near-term share
May 03, 2018 - Investor focus is likely to remain on Merrimack's (MACK) pipeline updates when it reports first-quarter numbers.
May 01, 2018 - Arris Group (NASDAQ:ARRS) turned in a mixed report in Q1 earnings, substantially trimming its net loss but seeing revenues fall short of expectations. Net loss on a GAAP basis was $0.07/share, vs. a
May 01, 2018 - The thesis for position #18, Ionis Pharmaceuticals, has been added.Weakness in the overall market and biotech sector continues to frustrate (and scare) many investors.I remind readers that I am not a
Apr 30, 2018 - Apple will have a weak quarter.Wal-Mart and Apple will be the biggest losers from a trade war with China.Chegg is a consistent company.
Apr 30, 2018 -
On CNBC's "Mad Money", Jim Cramer advised his viewer to be careful with Array Biopharma Inc (NASDAQ: ARRY) because the market is taking apart the minor drug companies.